Int. J. Mol. Sci. 2013, 14(9), 18925-18958; doi:10.3390/ijms140918925
Review

The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients

Received: 4 June 2013; in revised form: 26 August 2013 / Accepted: 30 August 2013 / Published: 13 September 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed.
Keywords: circulating cell free DNA; neoplasms; early diagnosis; follow up on cancer treatment; prognosis
PDF Full-text Download PDF Full-Text [297 KB, uploaded 19 June 2014 05:09 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Elshimali, Y.I.; Khaddour, H.; Sarkissyan, M.; Wu, Y.; Vadgama, J.V. The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients. Int. J. Mol. Sci. 2013, 14, 18925-18958.

AMA Style

Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV. The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients. International Journal of Molecular Sciences. 2013; 14(9):18925-18958.

Chicago/Turabian Style

Elshimali, Yahya I.; Khaddour, Husseina; Sarkissyan, Marianna; Wu, Yanyuan; Vadgama, Jaydutt V. 2013. "The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients." Int. J. Mol. Sci. 14, no. 9: 18925-18958.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert